Abstract

In the event of a terrorist-mediated attack in the United States using radiological or improvised nuclear weapons, it is expected that hundreds of thousands of people could be exposed to life-threatening levels of ionizing radiation. We have recently shown that genome-wide expression analysis of the peripheral blood (PB) can generate gene expression profiles that can predict radiation exposure and distinguish the dose level of exposure following total body irradiation (TBI). However, in the event a radiation-mass casualty scenario, many victims will have heterogeneous exposure due to partial shielding and it is unknown whether PB gene expression profiles would be useful in predicting the status of partially irradiated individuals. Here, we identified gene expression profiles in the PB that were characteristic of anterior hemibody-, posterior hemibody- and single limb-irradiation at 0.5 Gy, 2 Gy and 10 Gy in C57Bl6 mice. These PB signatures predicted the radiation status of partially irradiated mice with a high level of accuracy (range 79–100%) compared to non-irradiated mice. Interestingly, PB signatures of partial body irradiation were poorly predictive of radiation status by site of injury (range 16–43%), suggesting that the PB molecular response to partial body irradiation was anatomic site specific. Importantly, PB gene signatures generated from TBI-treated mice failed completely to predict the radiation status of partially irradiated animals or non-irradiated controls. These data demonstrate that partial body irradiation, even to a single limb, generates a characteristic PB signature of radiation injury and thus may necessitate the use of multiple signatures, both partial body and total body, to accurately assess the status of an individual exposed to radiation.

Highlights

  • In the event of a terrorist-driven detonation of an improvised nuclear device (IND) in a populated U.S city, it is expected that hundreds of thousands of people could be exposed to ionizing radiation, with even larger numbers fearful that they have been exposed [1,2,3,4]

  • We subsequently applied this same approach to predicting the radiation status of humans who received total body irradiation (TBI) prior to stem cell transplantation as compared to non-irradiated patients and healthy human controls and found that a peripheral blood (PB) signature of 25 genes was capable of predicting the radiation status of humans with an overall accuracy of 95% [10]

  • PB signature of anterior hemibody (AH) irradiation We first sought to determine if irradiation of one-half of the body could produce a PB gene expression response that was characteristic of that level of radiation exposure and whether irradiation of the AH, PH or HL produced unique PB gene expression profiles

Read more

Summary

Introduction

In the event of a terrorist-driven detonation of an improvised nuclear device (IND) in a populated U.S city, it is expected that hundreds of thousands of people could be exposed to ionizing radiation, with even larger numbers fearful that they have been exposed [1,2,3,4]. Utilizing a binary regression analysis, patterns of gene expression (50–100 genes) were identified in the PB of mice that were capable of predicting radiation status and distinguishing the dose level of exposure between non-irradiated, 0.5 Gy-, 2 Gy- and 10 Gy-irradiated animals with accuracy of 96% [9] We subsequently applied this same approach to predicting the radiation status of humans who received total body irradiation (TBI) prior to stem cell transplantation as compared to non-irradiated patients and healthy human controls and found that a PB signature of 25 genes was capable of predicting the radiation status of humans with an overall accuracy of 95% [10]. These studies confirmed the power of PB gene expression profiles or ‘‘metagenes’’ to predict the radiation status of people and provided the basis for our current effort to develop a rapid, high throughput biodosimetry assay for application in a radiation mass casualty scenario

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call